Abstract
Abstract Skeletal diseases caused by excessive activation of osteoclasts seriously affect elderly’s health. Therefore, inhibiting excessive activation of osteoclasts become effective therapeutic strategy for osteoporosis. Celery, a traditional and popular Chinese vegetable with high nutritional value, is rich in flavonoids which have a variety of pharmacological activities. The present study aimed to determine the pharmacological effect of total flavonoids of celery (TFC) on osteoclastogenesis, and to explore the molecular mechanisms. Results showed that TFC inhibited osteoclast differentiation and bone resorption without significant toxic and side effect. Furthermore, the results of western blot analysis and qPCR indicated that TFC inhibited the degradation of IκBα, phosphorylation of NF-κB and p38, and subsequently attenuated the expression levels of osteoclast-specific genes. The results of this study may have a positive impact on the application of TFC as functional food ingredients, which has potential preventive and therapeutic effects on osteoclast-related diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.